ASX:NOX
Market Cap:
Price Delay ~20min
Interactive 2020
Annual Report

Media

14-Jan-2021

Australian pharmaceutical industry news site, Health Industry Hub also reports, "Australia's Noxopharm advances NOXCOVID study".

Read more here. 

13-Jan-2021

The West Australian Newspaper reported today on Noxopharm's announcement that its European NOXCOVID trial in COVID-19 patients has been cleared to administer to the fifth and final dosage cohort.

Read more here. 

13-Jan-2021

Business News Australia reported that Noxopharm's COVID-19 treatment trial advances to the final stage.

Read more here.

13-Jan-2021

The Market Herald reported, "Noxopharm (ASX:NOX) cleared to up dosage in COVID study

Read more here.

13-Jan-2021

Australian Online News business news section reported on Noxopharm's COVID-19 treatment trial:

Read more here. 

24-Dec-2020

Australian Financial Services company, Reach Markets, interviewed CEO Dr Graham Kelly for their December Newsletter.

To read more click here;

6-Dec-2020

Health Industry Hub, Australian digital news site for Pharma, MedTech and Biotech industries and key industry stakeholders, informed;

Click here to read further

3-Dec-2020

French language news site dedicated to health technologies, Biotech Finances, covered the recent announcement;

Click here to read more

3-Dec-2020

A resource for life-sciences executives and other healthcare-service related professionals" posted the following News Release;

Click here to read more

3-Dec-2020

BioSpace, the Life Science industry digital news and information source reported,

Click here to read more